Purchase Order 15BBR026P00000020
- Not listed
- McKesson Corporation, a major healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, was awarded a delivery order by the Metropolitan Detention Center Brooklyn (a civilian facility under the Department of Justice) on October 1, 2024, with a ceiling value of $49,177.60. This firm fixed-price contract, with an ultimate completion date of November 25, 2025, carries no set-aside designation and represents a competitive large business award. The work will be...
- This federal contract award is for the delivery of pharmaceutical products to the Metropolitan Detention Center Brooklyn, a civilian agency under the Department of Justice. The $7,000 firm fixed-price purchase order was awarded to McKesson Corporation, a prominent healthcare services and IT company, to provide pharmaceuticals for inmates. The contract has an ultimate completion date of July 17, 2025. No set-aside designation was used for this award, indicating McKesson competed as a large...
- This is a federal contract award from the U.S. Department of Justice's Metropolitan Detention Center Brooklyn to provide pharmaceutical products for the inmate population. The contract was awarded to the prime contractor, Mckesson Corporation, a large for-profit healthcare services and information technology company headquartered in Irving, Texas. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $945,000.00 and a period of performance ending on September 30, 2025. The...
- The Department of Justice Bureau of Prisons Metropolitan Detention Center Brooklyn awarded a $1.3 million firm fixed price delivery order contract to McKesson Corporation, doing business as McKesson, for prime vendor pharmaceutical services. Under this contract, McKesson will provide pharmaceutical products to the Metropolitan Detention Center Brooklyn through December 2023 in support of the Bureau of Prisons' operations. No subcontractors or set aside designations were identified. McKesson will...
- Mckesson Corporation has been awarded a firm fixed price delivery order against an indefinite delivery contract with the Department of Justice's Bureau of Prisons Metropolitan Detention Center Guaynabo. The $14,566.12 order is for B1 MCKESSON MAT 90F RP 24-0031, to be completed by March 8, 2024. No set-aside designation was used for this award. Mckesson will provide unspecified pharmaceutical products to the Bureau of Prisons facility in Irving, Texas to support the agency's federal correctional...
- McKesson Corporation has been awarded a firm fixed price purchase order by the Department of Justice Bureau of Prisons Federal Correctional Complex Coleman in Irving, Texas. The award, titled "MCKESSON OPEN MARKET SEPTEMBER 2023," has a potential value of $10,000 and delivery is required by March 5, 2024. No set-aside designation was applied. McKesson will provide unspecified pharmaceutical products to the Bureau of Prisons facility under this purchase order. As a leading healthcare...
- Mckesson Corporation will deliver pharmaceutical products to the Metropolitan Detention Center Brooklyn on behalf of the Department of Justice Bureau of Prisons under a firm fixed price delivery order valued at fifteen thousand dollars. Issued against an unidentified prime vendor pharmaceutical contract vehicle, the one month order covers narcotics and runs from October 1st through November 17th, 2023. Place of performance will be Mckesson's distribution facility in Irving, Texas. No...
- Mckesson Corporation, doing business as Mckesson, has been awarded a $1,417.80 firm fixed price purchase order by the Department of Justice Bureau of Prisons Federal Correctional Complex Pollock (DOJ-BOP) to provide pharmaceuticals. Performance will take place in Irving, Texas under a two-week period starting August 16th and concluding August 31st, 2023. No additional details were provided on the original solicitation or products/services requested. The award is not associated with a larger...
- McKesson Corporation was awarded a $11,768.30 firm fixed price delivery order against an unidentified contract vehicle to supply controlled medical replenishment products to the Department of Justice Bureau of Prisons Metropolitan Detention Center Guaynabo located in Irving, Texas. Per the award details, McKesson will deliver the requested supplies by February 2024. As the prime contractor, McKesson will utilize its distribution infrastructure to provide the Bureau of Prisons facility with the...
- McKesson Corporation, doing business as McKesson, has been awarded a firm fixed price purchase order valued at approximately $2,344 by the Department of Justice Bureau of Prisons Federal Correctional Complex Pollock. The contract is for pharmaceutical supplies to support the Bureau of Prisons facility in Irving, Texas. McKesson will deliver the pharmaceutical products to the specified location between November 8-30, 2023. No subcontractors or set aside designations were indicated. McKesson is...
McKesson Corporation has been awarded a purchase order by the Metropolitan Detention Center Brooklyn for the supply of pharmaceuticals for inmates, effective October 1, 2025, through September 30, 2026. This firm fixed-price contract carries a ceiling value of $7,000 and represents a non-competed, large business award with no small business set-aside designation. The work will be performed from McKesson's location in Irving, Texas, where the company maintains its primary headquarters and pharmaceutical distribution operations. This award aligns with McKesson's established role as a critical pharmaceutical supplier to the Federal Bureau of Prisons and other Department of Justice correctional facilities. The company has developed extensive experience providing controlled and non-controlled medications, medical consumables, and specialty pharmaceuticals to federal detention centers and prisons nationwide. As a healthcare services and information technology company with significant federal contract infrastructure—including a $25.5 million Blanket Purchase Agreement with the Department of Homeland Security's Customs and Border Protection for medical supplies—McKesson maintains the operational capacity and compliance frameworks necessary to reliably support the pharmaceutical needs of federal correctional institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 12/11/25 |